InnoPharmax Inc. (4172.TWO)

TWD 17.1

(-0.87%)

Gross Profit Summary of InnoPharmax Inc.

  • InnoPharmax Inc.'s latest annual gross profit in 2023 was 17.45 Million TWD , up 4730.5% from previous year.
  • InnoPharmax Inc.'s latest quarterly gross profit in 2024 Q2 was 6.4 Million TWD , down 0.0% from previous quarter.
  • InnoPharmax Inc. reported a annual gross profit of -377 Thousand TWD in annual gross profit 2022, down -105.08% from previous year.
  • InnoPharmax Inc. reported a annual gross profit of 7.41 Million TWD in annual gross profit 2021, down -87.25% from previous year.
  • InnoPharmax Inc. reported a quarterly gross profit of 6.4 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • InnoPharmax Inc. reported a quarterly gross profit of 5.37 Million TWD for 2023 Q2, down 0.0% from previous quarter.

Annual Gross Profit Chart of InnoPharmax Inc. (2023 - 2019)

Historical Annual Gross Profit of InnoPharmax Inc. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 17.45 Million TWD 4730.5%
2022 -377 Thousand TWD -105.08%
2021 7.41 Million TWD -87.25%
2020 58.14 Million TWD 70.69%
2019 34.06 Million TWD 0.0%

Peer Gross Profit Comparison of InnoPharmax Inc.

Name Gross Profit Gross Profit Difference
Allied Biotech Corporation 246.43 Million TWD 92.916%
GeneFerm Biotechnology Co., Ltd. 286.35 Million TWD 93.904%
Easywell Biomedicals, Inc. 170.71 Million TWD 89.774%
TTY Biopharm Company Limited 3.22 Billion TWD 99.458%
Synmosa Biopharma Corporation 2.11 Billion TWD 99.177%
Orient EuroPharma Co., Ltd. 2.14 Billion TWD 99.187%
Center Laboratories, Inc. 618.09 Million TWD 97.176%
Tien Liang BioTech Co., Ltd. 286.14 Million TWD 93.899%
Orient Pharma Co., Ltd. 468.66 Million TWD 96.275%
Johnson Chemical Pharmaceutical Works Co., Ltd. 244.63 Million TWD 92.864%
Excelsior Biopharma Inc. 306.93 Million TWD 94.312%
DV Biomed Co., Ltd. 764.27 Million TWD 97.716%
Foresee Pharmaceuticals Co., Ltd. 113.97 Million TWD 84.683%
Handa Pharmaceuticals, Inc. 1.1 Billion TWD 98.42%
UniPharma Co., Ltd. 51.01 Million TWD 65.781%
Anxo Pharmaceutical Co., Ltd. 396.93 Million TWD 95.602%
Alar Pharmaceuticals Inc. 465.92 Million TWD 96.253%
Winston Medical Supply Co., Ltd. 347.59 Million TWD 94.978%
Mercury Biopharmaceutical Corporation 592 Thousand TWD -2848.818%
Bioray Biotech Co., Ltd 77.65 Million TWD 77.519%
TSH Biopharm Corporation Limited 399.89 Million TWD 95.635%